FDA Grants Orphan Drug Designation to Ganaxolone for Lennox-Gastaut Syndrome
Prior to the end of March 2023, ganaxolone had received six separate Orphan Drug designations from the FDA; more recently, as shared in a news release from commercial-stage pharmaceutical…